42 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
exchange contracts or any other hedging arrangements as of December 31, 2023.
F-14
ENLIVEX THERAPEUTICS LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS … , the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
credit risk exists with respect to these investments.
The Company had no foreign exchange contracts or any other hedging arrangements as of December 31 … Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
) and Derivatives and Hedging: Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 simplifies the complexity associated
6-K
EX-99.1
8maxum7lx3p
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
wnbgu
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-1.1
kuqi8f59xsxre7
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-99.1
zxzpt52sp2i9n4
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
ewsa6b
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K/A
EX-99.2
7evbopxqe468r3kue xr
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K/A
EX-99.1
kopwc9ftz5975km1
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.2
h8w0uje
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
lv10 xca6d50b0
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.2
uyp5gg485bw2o3r p5hj
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
6qmpy36klxinqzt97 00
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-4.2
wa5464v5pn0dt
5 Mar 20
Report of Foreign Private Issuer
8:16am